Technical Analysis for NMRD - Nemaura Medical Inc.

Grade Last Price % Change Price Change
F 0.00 -99.38% -0.03
NMRD closed down 35.6 percent on Friday, August 23, 2024, on 1 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
Earnings due: Nov 4
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish -99.38%
Fell Below 50 DMA Bearish -99.38%
Boomer Buy Setup Bullish Swing Setup -99.38%
Narrow Range Bar Range Contraction -99.38%
Inside Day Range Contraction -99.38%
Wide Bands Range Expansion -99.38%
Gapped Down Weakness -99.38%
20 DMA Support Bullish -99.60%
50 DMA Support Bullish -99.60%
MACD Bullish Centerline Cross Bullish -99.60%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Nemaura Medical Inc. Description

Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Diabetes Medical Device Glucose Endocrine System Blood Test Wireless Devices Diabetes Mellitus Medical Monitoring Blood Glucose Monitoring Endocrinology Type I Diabetes Blood Sugar Level Continuous Glucose Monitor Type II Diabetes

Is NMRD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.973
52 Week Low 0.0292
Average Volume 10,485
200-Day Moving Average 0.11
50-Day Moving Average 0.04
20-Day Moving Average 0.03
10-Day Moving Average 0.04
Average True Range 0.01
RSI (14) 45.36
ADX 33.33
+DI 45.83
-DI 11.15
Chandelier Exit (Long, 3 ATRs) 0.03
Chandelier Exit (Short, 3 ATRs) 0.06
Upper Bollinger Bands 0.05
Lower Bollinger Band 0.02
Percent B (%b) 0.39
BandWidth 69.54
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0014
Fundamentals Value
Market Cap 930.56 Thousand
Num Shares 28.9 Million
EPS -0.39
Price-to-Earnings (P/E) Ratio -0.08
Price-to-Sales 766.31
Price-to-Book 122.56
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.03
Resistance 3 (R3) 0.03 0.03 0.03
Resistance 2 (R2) 0.03 0.03 0.03 0.03
Resistance 1 (R1) 0.03 0.03 0.03 0.03 0.03
Pivot Point 0.03 0.03 0.03 0.03 0.03
Support 1 (S1) 0.03 0.03 0.03 0.03 0.03
Support 2 (S2) 0.03 0.03 0.03 0.03
Support 3 (S3) 0.03 0.03 0.03
Support 4 (S4) 0.03